The Japan IV Equipments market is anticipated to add more than USD 200 Million from 2023 to 2028.
Request for updated version of the report at the same price
Highend report of this product is available
Request for updated version of the report at the same price
Highend report of this product is available
Request for updated version of the report at the same price
Highend report of this product is available
Japan boasts a highly advanced and well-established healthcare infrastructure. The country is known for its modern hospitals, cutting-edge medical technologies, and a high standard of patient care. This advanced infrastructure includes the use of state-of-the-art IV equipment Japan has one of the world's most rapidly aging populations. With an increasing number of elderly individuals, there is a higher prevalence of chronic diseases that often require intravenous therapies. IV equipment plays a crucial role in delivering medications and nutrients to manage these conditions. There is a cultural emphasis on patient-centric care in Japan. This involves tailoring healthcare services to meet individual patient needs and preferences. IV equipment is selected and used with a focus on providing the best possible care experience for each patient. According to a 2022 report from the Japanese Ministry of Health, Labour and Welfare, there were an estimated 1.4 million people in Japan who used intravenous (IV) equipment in the past year. This number has been steadily increasing in recent years, as more and more people are diagnosed with chronic diseases that require IV therapy. The most common conditions requiring IV therapy in Japan are cancer, heart disease, and diabetes. IV Equipments are generally costly in Japan. The cost of IV equipment can vary depending on the specific type of equipment, the brand, and the retailer. First, Japan has a high standard of healthcare, and IV equipment is considered to be a critical medical device. This means that the government imposes strict regulations on the quality and safety of IV equipment, which can drive up the cost. Japan has a strong pharmaceutical industry, and many of the largest IV equipment manufacturers are Japanese companies. This can create a situation where there is less competition in the IV equipment market, which can also drive up prices. An IV pump can cost approximately US$ 85, while a common IV catheter can cost more than US$3.
According to the research report “Japan Intravenous (IV) Equipments Overview, 2028," published by Bonafide Research, the Japan IV Equipments market is anticipated to add more than USD 200 Million from 2023 to 2028. Japan is known for its commitment to technological innovation. In the IV equipment market, this translates to the development and adoption of advanced technologies, such as smart pumps, infusion monitoring systems, and devices with enhanced safety features. Patient safety is a top priority in the Japanese healthcare system. IV equipment in Japan is designed and used with a strong emphasis on safety standards, including features to prevent medication errors, infection control measures, and continuous monitoring capabilities. There has been a gradual shift towards the use of disposable IV systems in Japan. Disposable IV sets and components are preferred for their convenience, reduced risk of contamination, and ease of disposal. Smart infusion pumps with features such as dose error reduction systems (DERS), wireless connectivity, and integration with electronic medical records (EMRs) are becoming more prevalent in Japan. These pumps enhance accuracy, reduce medication errors, and improve workflow efficiency. The COVID-19 pandemic has accelerated the adoption of telemedicine in Japan. This trend includes the use of remote monitoring solutions integrated with IV equipment, allowing healthcare providers to track patients' conditions and adjust treatments remotely. For patients requiring insulin therapy or glucose control, there is a trend toward the integration of IV equipment with continuous blood glucose monitoring systems. This integration allows for more precise control and adjustments in insulin administration.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleCustomise your report by selecting specific countries or regions
Specify Scope NowOne individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
We offer 10% Free Customization at the time of purchase
Get Free CustomizationWe sent OTP in your email & phone
Check your spam/junk folder as well
We are friendly and approachable, give us a call.
We use cookies to ensure you get the best experience on our website.